BERLIN -- Combining enzalutamide (Xtandi) with androgen deprivation therapy (ADT) significantly improved overall survival (OS ...

Men with prostate cancer that returns after surgery or radiation and are left with few options could benefit from a new ...

Prostate cancer is the most common cancer among men after skin cancer, with approximately 1 in 8 men diagnosed in their ...

TUESDAY, Oct. 14, 2025 (HealthDay News) — Former President Joe Biden is now receiving radiation and hormone therapy to treat ...

The 82-year-old former president left the hour-long service, walking slowly and holding onto a woman for support.

There is no single, diagnostic test for prostate cancer and PSA tests are not routinely used to screen healthy men because ...

A new drug combination to treat advanced recurring prostate cancer has shown remarkable results in a long-term trial, ...

Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...

A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...

At 82, President Joe Biden is undergoing radiation and hormone therapy for prostate cancer. Here's what you need to learn ...

Prostate cancer treatment could be "supercharged" by a new way of weakening malignant cells, say scientists in Australia.

SpaceOAR Hydrogel is a polyethylene glycol–based hydrogel designed to create space between the prostate and rectum to reduce ...